Preclinical Applications of Simultaneous PET/MRI
Preclinical Applications of Simultaneous PET/MRI

Preclinical Applications of Simultaneous PET/MRI

On Demand Session

Webinar Overview

In this webinar, Dr. Iris Zhou covers a range of PET/MR applications entailing neurology, oncology, and liver fibrosis, as well as contrast agent development in both mice and rats, and proves, as she says, the applications are “limited only by imagination”.


Dr. Zhou demonstrates the strengths of PET and MR and the combination of both with applications performed on the BioSpec 4.7 T with PET insert. She describes multi-mouse 11C studies of dopamine release and microglia dysregulation with multi-rat imaging and discusses the practicalities of carrying out multi-rodent studies. She then illuminates work on gastric cancer, where results can be used to stratify patients for more efficient treatment, non-alcoholic steatoheptatitis for early detection of fibrosis, and renal impairment, where results show a compensation via liver excretion, before covering contrast agent development.


She also describes 86Y as surrogate for Gd3+ as they are bother similar in size and chemistry, and shows via co-injection of both in rat that Gd3+ concentration can be determined. She further discusses how her studies with 52-labeled Mn DPDP for dual PET and MR imaging allow identification of where Mn is going on the long term.

Key Learnings

Multi-rodent Neuro Imaging

  •  Technicalities of multi-rodent imaging
  • Dopamine release
  • Microglia dysregulation

Abdominal Imaging

  • Gastric cancer
  • NASH, Non-alcoholic steatoheptatitis
  • Renal impairment

Contrast Agent Development

  • 86Y as surrogate for Gd3+
  • 52-labeled Mn DPDP

Who should attend?

Researchers wishing to gain an overview of a wide range of developments within the PET/MR imaging field will find this webinar to be an excellent critique.

Speakers

Dr. Iris Zhou
Instructor - Radiology
Massachusetts General Hospital & Harvard University

Dr. Iris Zhou is an instructor in Radiology at Massachusetts General Hospital and Harvard Medical School. Her research focuses on developing novel imaging biomarkers to quantify molecular information of stroke, tumor, and fibrotic diseases, and applying them to track disease progression and monitor therapeutic interventions.

Registration

Input value is invalid.

Are you already in contact with your Bruker representative regarding any product inquiries?

We constantly want to improve our service for our customers. In answering the following question you help us to serve your needs even better in the future: What best describes your situation?

By ticking this box, I agree to receive, from time to time, emails from Bruker and its affiliates within the Bruker Group on upcoming events, webinars, our products and services, surveys and Bruker's corporate news.
I can unsubscribe at any time, by contacting Bruker or clicking on the opt-out link in the email if available. For more information on the processing of your personal data, please check Bruker’s Privacy Policy. 

By submitting this form I agree my personal data will be used to process my registration to the webinar. I have read and accepted the Bruker Website Privacy Notice (https://www.bruker.com/privacy-policy.html) and I agree to the Terms of Use (https://www.bruker.com/terms-of-use.html) of the Bruker website.

Already registered and lost your invitation link?

Thank you. The invitation link has been resent.